Cagent Vascular key facts
as of Oct 2026- Developer of an intravascular technology designed to treat diseased peripheral arteries.
- Cagent Vascular is valued at approximately $80.7M as of Oct 2026 (last reported valuation).
- It has raised $73.2M across 5 recorded rounds; the latest was Early Stage VC ($24.5M) in May 2026.
- Notable investors include Ben Franklin Technology Partners of Southeastern Pennsylvania, BF Belmont, Balestier Investments, Blue Ridge Medical., M&L Group — 10 tracked in total.
- Cagent Vascular has filed 7 Form Ds with the SEC since 2014, most recently Jun 2026 ($24.5M sold to 51 investors).
- Status: Privately Held (backing).
Cagent Vascular's last reported valuation, Jan 2024. Nothing priced has surfaced since.
- ·Watch Cagent Vascular: the Monday email on marks, rounds and moves
Cagent Vascular funding rounds
5 roundsCagent Vascular valuation
Cagent Vascular's last reported valuation was $80.7 million in Jan 2024. No priced round, secondary trade or fund mark has surfaced since.
How much has Cagent Vascular raised?
Cagent Vascular has raised $73.2 million across 5 recorded rounds since 2017. The largest was a $9.5 million early-stage round in Jun 2021; the most recent was a $24.5 million early-stage round in May 2026.
Cagent Vascular has filed 7 Form Ds with the SEC since 2014, most recently in Jun 2026 ($24.5 million sold to 51 investors).
Cagent Vascular investors
10 investors are on record for Cagent Vascular, including Ben Franklin Technology Partners of Southeastern Pennsylvania, BF Belmont, Balestier Investments and Blue Ridge Medical.. The early-stage round in May 2026 drew 51 investors.
About Cagent Vascular
Developer of an intravascular technology designed to treat diseased peripheral arteries. The company's technology is a minimally invasive device for vessel dilatation in cardiovascular disease interventions with multiple longitudinal lines of interrupted micro-serrations used for arterial expansion along those lines, enabling healthcare providers to improve the lives of patients.
- Sector
- Healthcare
- HQ
- Wayne, PA, United States
- Founded
- 2014
- Employees
- 78
- Website
- cagentvascular.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.